VWM
VRTX icon

Valley Wealth Managers’s Vertex Pharmaceuticals VRTX Stock Holding History

Valley Wealth Managers’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.5M Buy
51,329
+1,190
+2% +$527K 1.47% 23
2026
Q1 		$22.4M Sell
50,139
-812
-2% -$379K 1.44% 30
2025
Q4 		$23.1M Buy
50,951
+1,132
+2% +$488K 1.48% 27
2025
Q3 		$19.5M Buy
49,819
+1,130
+2% +$472K 1.29% 38
2025
Q2 		$21.7M Sell
48,689
-795
-2% -$366K 1.56% 24
2025
Q1 		$24M Sell
49,484
-1,040
-2% -$485K 1.82% 14
2024
Q4 		$20.3M Buy
50,524
+50
+0.1% +$23.2K 1.52% 24
2024
Q3 		$23.5M Sell
50,474
-1,006
-2% -$483K 1.74% 11
2024
Q2 		$24.1M Sell
51,480
-3,723
-7% -$1.62M 1.92% 8
2024
Q1 		$23.1M Sell
55,203
-4,093
-7% -$1.73M 1.74% 13
2023
Q4 		$24.1M Sell
59,296
-1,600
-3% -$591K 1.88% 8
2023
Q3 		$21.2M Sell
60,896
-3,170
-5% -$1.11M 1.77% 11
2023
Q2 		$22.5M Sell
64,066
-4,268
-6% -$1.44M 2.02% 10
2023
Q1 		$21.5M Sell
68,334
-3,913
-5% -$1.17M 1.96% 11
2022
Q4 		$20.9M Sell
72,247
-6,879
-9% -$2.1M 1.94% 14
2022
Q3 		$22.9M Sell
79,126
-6,699
-8% -$1.93M 2.29% 3
2022
Q2 		$24.2M Sell
85,825
-4,678
-5% -$1.25M 2.26% 4
2022
Q1 		$23.6M Sell
90,503
-4,735
-5% -$1.12M 1.97% 11
2021
Q4 		$20.9M Sell
95,238
-1,125
-1% -$219K 1.68% 19
2021
Q3 		$17.5M Buy
+96,363
New +$18.8M 1.52% 31
2017
Q1 		– Sell
-32
Closed -$2K – 247
2016
Q4 		$2K Buy
+32
New +$2.6K ﹤0.01% 231

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Valley Wealth Managers's VRTX Position: Q2 2026 in Review

Valley Wealth Managers increased its Vertex Pharmaceuticals (VRTX) stake by 2.4% in Q2 2026, buying an estimated $527K and bringing the position to 51,329 shares worth $25.5M. The position accounts for 1.47% of the portfolio, ranked #23.

Valley Wealth Managers first reported a position in VRTX in Q4 2016 and has held it in 21 quarters since. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Valley Wealth Managers held 51,329 shares of Vertex Pharmaceuticals worth $25.5M as of Q2 2026.
  • Valley Wealth Managers bought 1,190 Vertex Pharmaceuticals shares in Q2 2026, an estimated $527K.
  • Vertex Pharmaceuticals made up 1.47% of Valley Wealth Managers's portfolio in Q2 2026, its #23 holding.
  • Valley Wealth Managers first reported a position in Vertex Pharmaceuticals in Q4 2016 and has held it in 21 quarters since.
  • 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Valley Wealth Managers's 13F filing for Q2 2026, filed 4 Aug 2026.